Belarus vs South Sudan: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Belarus
16.0%
in 2025
South Sudan
27.0%
in 2025
Belarus rank
163rd
South Sudan rank
161st
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Belarus
- South Sudan
How they compare
South Sudan currently reports 27.0% against 16.0% in Belarus, a difference of 11.0%.
That makes South Sudan's figure about 1.7 times Belarus's.
Across all 15 years both countries report, South Sudan has been ahead every year.
Belarus ranks 163rd and South Sudan ranks 161st of 192 countries.
South Sudan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Belarus | South Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.0% | 0.0% | 0.0% | — |
| 2020s | 2.7% | 4.5% | 1.8% | South Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Belarus or South Sudan?
- South Sudan, at 27.0% against 16.0% in Belarus as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Belarus and South Sudan?
- 11.0%, with South Sudan ahead.
- How many years of comparable data are there for Belarus and South Sudan?
- 15 years are reported by both, from 2011 to 2025.
- How do Belarus and South Sudan rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Belarus ranks 163rd and South Sudan ranks 161st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.